| Price | 6,350.00on 18-03-2019 at 16:30:00 |
|---|---|
| Change | 76.00 1.21% |
| Buy | 6,350.00 |
| Sell | 6,347.00 |
| Buy / Sell AZN Shares | |
| Last Trade: | Buy 13,039 at 6,350.00p |
| Day's Volume: | 1,139,417 |
| Last Close: | 6,274.00p |
| Open: | 6,290.00p |
| ISIN: | GB0009895292 |
| Day's Range | 6,290.00p - 6,364.00p |
| 52wk Range: | 4,746.00p - 6,432.00p |
| Market Capitalisation: | £80,441m |
| VWAP: | 0.00p |
| Shares in Issue: | 1,267m |
Recent Trades History Astrazeneca (AZN) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 13,039 | 6,350.00 | Ordinary Delayed publication | 17:13:53 - 18-Mar-19 |
| Buy* | 150 | 6,350.00 | 17:29:50 - 18-Mar-19 | |
| Buy* | 3,789 | 6,350.779 | 17:31:40 - 18-Mar-19 | |
| Buy* | 86 | 6,411.782 | 17:31:15 - 18-Mar-19 | |
| Sell* | 730 | 6,337.197 | 17:30:48 - 18-Mar-19 | |
| Buy* | 73 | 6,392.190 | 17:30:42 - 18-Mar-19 | |
| Buy* | 13,368 | 6,350.00 | 17:27:58 - 18-Mar-19 | |
| Sell* | 60 | 6,312.367 | 17:23:22 - 18-Mar-19 | |
| Buy* | 38,091 | 6,359.915 | 17:19:59 - 18-Mar-19 | |
| Sell* | 4,591 | 6,341.284 | 17:17:44 - 18-Mar-19 | |
Share Price History for Astrazeneca |
|||||
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 18th Mar 2019 (Mon) | 6,290.00 | 6,364.00 | 6,290.00 | 6,274.00 | 1,139,417 |
| 15th Mar 2019 (Fri) | 6,311.00 | 6,331.00 | 6,253.00 | 6,309.00 | 7,944,281 |
| 14th Mar 2019 (Thu) | 6,319.00 | 6,327.00 | 6,262.00 | 6,293.00 | 3,186,252 |
| 13th Mar 2019 (Wed) | 6,267.00 | 6,318.00 | 6,262.00 | 6,283.00 | 1,468,911 |
| 12th Mar 2019 (Tue) | 6,283.00 | 6,318.00 | 6,204.00 | 6,315.00 | 1,887,475 |
| 11th Mar 2019 (Mon) | 6,300.00 | 6,372.00 | 6,280.00 | 6,271.00 | 1,363,329 |
| 8th Mar 2019 (Fri) | 6,254.00 | 6,292.00 | 6,222.00 | 6,258.00 | 1,809,787 |
| 7th Mar 2019 (Thu) | 6,281.00 | 6,305.00 | 6,215.00 | 6,306.00 | 2,087,047 |
| 6th Mar 2019 (Wed) | 6,325.00 | 6,362.00 | 6,290.00 | 6,297.00 | 1,427,734 |
| 5th Mar 2019 (Tue) | 6,234.00 | 6,311.00 | 6,208.00 | 6,212.00 | 1,688,620 |
| 4th Mar 2019 (Mon) | 6,203.00 | 6,248.00 | 6,137.00 | 6,186.00 | 1,555,208 |
| 1st Mar 2019 (Fri) | 6,216.00 | 6,226.00 | 6,146.00 | 6,139.00 | 1,866,683 |
| 28th Feb 2019 (Thu) | 6,200.00 | 6,200.00 | 6,107.00 | 6,283.00 | 2,828,489 |
| 27th Feb 2019 (Wed) | 6,248.00 | 6,283.00 | 6,204.00 | 6,271.00 | 1,954,006 |
| 26th Feb 2019 (Tue) | 6,259.00 | 6,283.00 | 6,153.00 | 6,290.00 | 2,541,507 |
| 25th Feb 2019 (Mon) | 6,200.00 | 6,302.00 | 6,156.00 | 6,159.00 | 1,830,651 |
| 22nd Feb 2019 (Fri) | 6,100.00 | 6,197.00 | 6,081.00 | 6,096.00 | 1,729,486 |
| 21st Feb 2019 (Thu) | 6,125.00 | 6,164.00 | 6,070.00 | 6,143.00 | 1,684,015 |
| 20th Feb 2019 (Wed) | 6,102.00 | 6,176.00 | 6,072.00 | 6,093.00 | 1,837,718 |
| 19th Feb 2019 (Tue) | 6,155.00 | 6,185.00 | 6,061.00 | 6,156.00 | 2,470,885 |
News - Monday, July 17, 2017
The FTSE 100 made some modest gains on Monday, thanks to the strength of miners who themselves benefited from strong Chinese GDP data. Meanwhile, the pound slipped as the second round of Brexit talks began....
News - Sunday, May 14, 2017
The FTSE 100 ended the week on a high note, benefiting from a strong performance by AstraZeneca after the drug company reported that its recent trial of a cancer drug had showed promising results. The company was trialling an immunotherapy drug called Imfinzi, which it had found could lower the risk of stage III lung cancer worsening or becoming fatal....
